Title of article
Biopharmaceuticals and Nutraceuticals Produced in Yeasts and the Clinical Management Related to COVID-19 Disease
Author/Authors
Arianfar ، Farzane Department of Medical Biotechnology - Faculty of Allied Medicine - Iran University of Medical Sciences , Tarighi ، Parastoo Department of Medical Biotechnology - Faculty of Allied Medicine - Iran University of Medical Sciences , Shariatpanahi ، Marjan Department of Pharmacology and Toxicology - School of Pharmacy - Iran University of Medical Sciences , Mousavi Esfahani ، Mona Department of Medical Biotechnology - Faculty of Allied Medicine - Iran University of Medical Sciences , Mottaghi-Dastjerdi ، Negar Department of Pharmacognosy and Pharmaceutical Biotechnology - School of Pharmacy - Iran University of Medical Sciences
From page
65
To page
84
Abstract
Recently, the market demand for biopharmaceuticals and nutraceuticals has increased. Consequently, high-volume production strategies have also drawn a lot of attention. The invention and development of recombinant DNA technology, using various hosts from bacteria to mammalian cells, have led to the industrial-scale manufacture of many valuable pharmaceutical products. Among the hosts, yeasts have a special place due to their numerous benefits. The present study deals with commercial yeast-derived biopharmaceuticals and laboratory-scale yeast-extracted nutraceuticals. It represents the biotechnological potential of yeasts to meet the market’s needs in this area. Besides, considering the COVID-19 pandemic, the applications of yeast hosts for the clinical management of this disease have been briefly discussed.
Keywords
Biologicals , Biopharmaceuticals , COVID , 19 , Nutraceuticals , Yeast
Journal title
Research in Molecular Medicine
Journal title
Research in Molecular Medicine
Record number
2761523
Link To Document